Comparison Chart iTeos Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 15/05/2024 am IST			5-day change	1st Jan Change
16.72 ^USD	-1.76%		+35.82%	+52.69%

13/05	HC Wainwright Adjusts Price Target on iTeos Therapeutics to $46 From $44, Maintains Buy Rating	MT
10/05	Wedbush Adjusts iTeos Therapeutics' Price Target to $21 From $18, Maintains Outperform Rating	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	ITEOS THERAPEUTICS, INC.	Bio Therapeutic Drugs	-1.76%	+35.82%	+52.69%	+16.68%	-	623M